Restore Mind Medicine
Our History of Engagement
July 2019
Dr. Freeman co-founded MindMed and became Chief
Medical Officer and Executive President of MindMed.
June 2021 - May 2022
Dr. Freeman reached out to the Board to discuss many of
the problems afflicting Mind Med that persist today.
MindMed provided no substantive response and
mischaracterizes his offers to serve on the Board as a
request of entitlement.
August 2020
Dr. Freeman developed MindMed's clinical framework, recruited
key employees, and created the collaboration with the University
Hospital Basel. Dr. Freeman left the Company and is subject to
confidentiality agreement.
August 2022
After over two years of quietly attempting to engage with MindMed,
FCM was formed. FCM outlined its concerns in a public letter to the
Board outlining its Value Enhancement Plan which outlined a plan
for enhanced capital allocation, industry standard drug
development, cutting executive compensation, and using
shareholder equity judiciously.
9View entire presentation